Breast Imaging

ARRS: Get involved with breast health advocacy
By Amerigo Allegretto
At ARRS 2025, Amy Patel, MD, discussed the need for advocacy to drive legislation on insurance coverage for women with dense breasts.
May 2, 2025
In her ARRS 2025 presentation, Amy Patel, MD, discussed ways that radiologists can be proactive in influencing legislation that addresses breast density. These include working with elected officials and joining medical societies, among others.
ARRS: Most women under 40 have no imaging before breast cancer diagnosis
By Amerigo Allegretto
Most young women who are diagnosed with breast cancer had no prior imaging performed.
May 1, 2025
At ARRS 2025, Dana Kong from Case Western Reserve University presented on breast cancer trends among women aged 40 years and younger. Among her team's findings, young women who had imaging prior to their cancer diagnosis had higher receptor status and underwent surgery more frequently than those with no prior imaging.
Preop MRI fails to deliver results for breast cancer subtype
Preoperative MRI didn't improve outcomes in women with HER2-positive and hormone receptor-negative breast cancer in a new study.
April 29, 2025
Images show a palpable mass in the left breast in a 55-year-old woman. (A) Mammography shows a 26-mm ill-defined mass with fine linear calcifications in the central portion of the left breast (arrows). (B) ultrasound shows a 23-mm hypoechoic mass with calcifications in the corresponding area accompanying palpability (between the arrows). (C) An axial, fat-saturated, contrast-enhanced T1-weighted MRI scan shows an 18-mm irregular heterogeneous enhancing mass in the left breast (arrows). After breast-conserving surgery, the final pathologic report confirmed a grade II estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–positive invasive ductal carcinoma. There was no lymphovascular invasion, and the resection margins were clear. The patient declined both adjuvant chemotherapy and radiation therapy due to psychologic distress. (D) 11 months later, surveillance ultrasound helped to detect a new 25-mm irregular hypoechoic mass at the 12-o’clock position in the left breast (arrows). A subsequent ultrasound-guided biopsy confirmed it as a recurrence of grade II invasive ductal carcinoma, maintaining the same receptor statuses. Images courtesy of the RSNA.
ARRS: Most women OK with mammo data used to assess cancer risk
By Amerigo Allegretto
Most women are comfortable with having their mammogram data be used to calculate lifetime breast cancer risk
April 28, 2025
Mammogram Breast
ARRS: 'Report Cards' reduce BIRADS 3 usage
By Maryam Payne
"Report cards” were found to reduce rates of BI-RADS 3 assessment use, according to an award-winning poster presentation at ARRS 2025.
April 28, 2025
Breast Specialist Ultrasound Exam 400
Mammo uptake among veterans on par with nonveterans
By Amerigo Allegretto
Female veterans are as likely to undergo screening mammography as nonveteran women.
April 25, 2025
Mammogram Patient
ACS: Breast cancer screening rates have recovered post-COVID
By Kate Madden Yee
Rates of up-to-date breast cancer screening have recovered after declining during the COVID-19 pandemic.
April 23, 2025
Breast Screening Mammo
Ukrainian refugees at higher risk of advanced breast cancers
By Amerigo Allegretto
Displaced Ukrainian women have double the odds of having advanced-stage breast cancer compared with Polish citizens.
April 22, 2025
Ukrainian Flag
Report: Cancer incidence rates trending upward for women
By Liz Carey
New cancer diagnoses have been increasing slightly every year among women, but deaths from cancer have been declining steadily.
April 21, 2025
Cancer Maze (1)
More women welcome AI assistance for mammography exams
By Amerigo Allegretto
More women are willing to have AI assistance for their breast cancer screening exams.
April 18, 2025
Mammo Reading 400
RadNet inks $103M deal to purchase iCAD
By AuntMinnie.com staff writers
RadNet aims to broaden its breast imaging AI offerings with the acquisition of iCAD.
April 15, 2025
Rad Net Logo
Do radiologists trust mammography AI software?
By Erik L. Ridley
A large-scale prospective trial exploring the use of mammography AI software in a breast cancer screening program has found that recalls were lower when cases were flagged by AI.
March 18, 2025
Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.
Page 1 of 87
Next Page